What is a stock summary page? Click here for an overview.
Business Description
Excelsior Biopharma Inc
ISIN : TW0006496003
Description
Excelsior Biopharma Inc is mainly engaged in western medicines, importing and exporting of Active Pharmaceutical Ingredients, food, cosmecteuticals and development of cosmetics, research, importing, and exporting of technologies, pharmaceutical technologies transfer and cooperative development and improvement. Geographically, it derives revenue from Taiwan, China and others, with majority of revenue earned from Taiwan.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.57 | |||||
| Equity-to-Asset | 0.63 | |||||
| Debt-to-Equity | 0.44 | |||||
| Debt-to-EBITDA | -52.17 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 2.16 | |||||
| Beneish M-Score | -1.68 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -13.4 | |||||
| 3-Year EPS without NRI Growth Rate | -99.9 | |||||
| 3-Year Book Growth Rate | -7.5 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.52 | |||||
| 9-Day RSI | 48.4 | |||||
| 14-Day RSI | 46.27 | |||||
| 3-1 Month Momentum % | -9.18 | |||||
| 6-1 Month Momentum % | -1.18 | |||||
| 12-1 Month Momentum % | 5.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.43 | |||||
| Quick Ratio | 2.09 | |||||
| Cash Ratio | 1.11 | |||||
| Days Inventory | 192.49 | |||||
| Days Sales Outstanding | 70.47 | |||||
| Days Payable | 43.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.6 | |||||
| Shareholder Yield % | -5.92 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44.33 | |||||
| Operating Margin % | -9.13 | |||||
| Net Margin % | -11.45 | |||||
| FCF Margin % | -41.41 | |||||
| ROE % | -9.45 | |||||
| ROA % | -6.1 | |||||
| ROIC % | -8.28 | |||||
| 3-Year ROIIC % | -12.9 | |||||
| ROC (Joel Greenblatt) % | -9.98 | |||||
| ROCE % | -5.62 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 13.12 | |||||
| PS Ratio | 1.42 | |||||
| PB Ratio | 1.24 | |||||
| Price-to-Tangible-Book | 1.24 | |||||
| EV-to-EBIT | -17.91 | |||||
| EV-to-EBITDA | -169.08 | |||||
| EV-to-Revenue | 1.65 | |||||
| EV-to-FCF | -4.05 | |||||
| Price-to-GF-Value | 0.85 | |||||
| Price-to-Projected-FCF | 1.8 | |||||
| Price-to-Median-PS-Value | 0.84 | |||||
| Price-to-Net-Current-Asset-Value | 6.6 | |||||
| Earnings Yield (Greenblatt) % | -5.57 | |||||
| FCF Yield % | -28.92 | |||||
| Forward Rate of Return (Yacktman) % | -35.53 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Excelsior Biopharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 861.911 | ||
| EPS (TTM) (NT$) | -2.14 | ||
| Beta | -0.01 | ||
| 3-Year Sharpe Ratio | -0.12 | ||
| 3-Year Sortino Ratio | -0.18 | ||
| Volatility % | 19.07 | ||
| 14-Day RSI | 46.27 | ||
| 14-Day ATR (NT$) | 1.098781 | ||
| 20-Day SMA (NT$) | 26.65 | ||
| 12-1 Month Momentum % | 5.04 | ||
| 52-Week Range (NT$) | 21.55 - 40.15 | ||
| Shares Outstanding (Mil) | 46.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Excelsior Biopharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Excelsior Biopharma Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Excelsior Biopharma Inc Frequently Asked Questions
What is Excelsior Biopharma Inc(ROCO:6496)'s stock price today?
The current price of ROCO:6496 is NT$26.40. The 52 week high of ROCO:6496 is NT$40.15 and 52 week low is NT$21.55.
When is next earnings date of Excelsior Biopharma Inc(ROCO:6496)?
The next earnings date of Excelsior Biopharma Inc(ROCO:6496) is .
Does Excelsior Biopharma Inc(ROCO:6496) pay dividends? If so, how much?
Excelsior Biopharma Inc(ROCO:6496) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers